An in vitro approach to combat multidrug resistance in Salmonella typhi and human colon cancer with Excoecaria agallocha L. extract

Abstract Background The incidence of antibacterial resistance and colon cancer is increasing in India. Antibacterial resistance and chemoresistance demand the need of developing herbal or natural chemotherapeutic agents. Our study thus, aims to determine the antibacterial and anticancer activities o...

Full description

Bibliographic Details
Main Authors: Tamanna Sultana, Arup Kumar Mitra, Satadal Das
Format: Article
Language:English
Published: SpringerOpen 2021-12-01
Series:Bulletin of the National Research Centre
Subjects:
Online Access:https://doi.org/10.1186/s42269-021-00668-x
_version_ 1818834000179888128
author Tamanna Sultana
Arup Kumar Mitra
Satadal Das
author_facet Tamanna Sultana
Arup Kumar Mitra
Satadal Das
author_sort Tamanna Sultana
collection DOAJ
description Abstract Background The incidence of antibacterial resistance and colon cancer is increasing in India. Antibacterial resistance and chemoresistance demand the need of developing herbal or natural chemotherapeutic agents. Our study thus, aims to determine the antibacterial and anticancer activities of the leaf extracts of the mangrove Excoecaria agallocha. Results Liquid chromatography–mass spectroscopy analysis of the ethanolic E. agallocha extracts revealed the presence of Bergenin. The plant extract fraction containing Bergenin had potent antibacterial action against a resistant strain of Salmonella typhi with an MIC value of 15.7 ± 0.04 µg/mL. Treatment of the bacteria with the plant extract made it moderately susceptible to the antibacterial drugs ampicillin, aztreonam, cefotaxime, chloramphenicol and imipenem. The plant extract caused membrane damage and disrupted the expression of a 33 kDa outer membrane protein (OmpA) in S. typhi. It was plausibly due to this mechanism of the plant extract that made the bacteria susceptible to the antibacterial drugs to a certain extent. Further, fluorescence microscopy analysis revealed the anticancer property of the extract against a human colon cancer (DLD-1) cell line by activation of Caspase-3followed by subsequent apoptosis and exhibited cytotoxicity against the cancerous cell line with an IC50 value of 17.99 ± 1.12 µg/mL. Caspase-3 activity was observed to increase in a dose-dependent manner as determined by spectrophotometric assays. Moreover, the expression of the metalloproteinase-7 (MMP-7) was significantly reduced in plant extract treated DLD-1 colon cancer cells. Conclusion The results indicate that E. agallocha is a novel source of Bergenin, and the plant extract fraction under study may be used in combination therapy along with antibacterial drugs to combat antibacterial resistance of S. typhi and also to alleviate the risks of colon cancers in human. However, further investigations may be undertaken for its therapeutic application and to explore its potential bioactivity against other bacterial strains and human cancer cell lines.
first_indexed 2024-12-19T02:27:51Z
format Article
id doaj.art-fd689ae0ecff4a768199efea8fea677e
institution Directory Open Access Journal
issn 2522-8307
language English
last_indexed 2024-12-19T02:27:51Z
publishDate 2021-12-01
publisher SpringerOpen
record_format Article
series Bulletin of the National Research Centre
spelling doaj.art-fd689ae0ecff4a768199efea8fea677e2022-12-21T20:39:52ZengSpringerOpenBulletin of the National Research Centre2522-83072021-12-0145111210.1186/s42269-021-00668-xAn in vitro approach to combat multidrug resistance in Salmonella typhi and human colon cancer with Excoecaria agallocha L. extractTamanna Sultana0Arup Kumar Mitra1Satadal Das2Department of Microbiology, St. Xavier’s College (Autonomous)Department of Microbiology, St. Xavier’s College (Autonomous)Department of Microbiology, St. Xavier’s College (Autonomous)Abstract Background The incidence of antibacterial resistance and colon cancer is increasing in India. Antibacterial resistance and chemoresistance demand the need of developing herbal or natural chemotherapeutic agents. Our study thus, aims to determine the antibacterial and anticancer activities of the leaf extracts of the mangrove Excoecaria agallocha. Results Liquid chromatography–mass spectroscopy analysis of the ethanolic E. agallocha extracts revealed the presence of Bergenin. The plant extract fraction containing Bergenin had potent antibacterial action against a resistant strain of Salmonella typhi with an MIC value of 15.7 ± 0.04 µg/mL. Treatment of the bacteria with the plant extract made it moderately susceptible to the antibacterial drugs ampicillin, aztreonam, cefotaxime, chloramphenicol and imipenem. The plant extract caused membrane damage and disrupted the expression of a 33 kDa outer membrane protein (OmpA) in S. typhi. It was plausibly due to this mechanism of the plant extract that made the bacteria susceptible to the antibacterial drugs to a certain extent. Further, fluorescence microscopy analysis revealed the anticancer property of the extract against a human colon cancer (DLD-1) cell line by activation of Caspase-3followed by subsequent apoptosis and exhibited cytotoxicity against the cancerous cell line with an IC50 value of 17.99 ± 1.12 µg/mL. Caspase-3 activity was observed to increase in a dose-dependent manner as determined by spectrophotometric assays. Moreover, the expression of the metalloproteinase-7 (MMP-7) was significantly reduced in plant extract treated DLD-1 colon cancer cells. Conclusion The results indicate that E. agallocha is a novel source of Bergenin, and the plant extract fraction under study may be used in combination therapy along with antibacterial drugs to combat antibacterial resistance of S. typhi and also to alleviate the risks of colon cancers in human. However, further investigations may be undertaken for its therapeutic application and to explore its potential bioactivity against other bacterial strains and human cancer cell lines.https://doi.org/10.1186/s42269-021-00668-xAntibacterial resistanceBergeninCaspase-3Colon cancerExcoecaria agallochaMangrove
spellingShingle Tamanna Sultana
Arup Kumar Mitra
Satadal Das
An in vitro approach to combat multidrug resistance in Salmonella typhi and human colon cancer with Excoecaria agallocha L. extract
Bulletin of the National Research Centre
Antibacterial resistance
Bergenin
Caspase-3
Colon cancer
Excoecaria agallocha
Mangrove
title An in vitro approach to combat multidrug resistance in Salmonella typhi and human colon cancer with Excoecaria agallocha L. extract
title_full An in vitro approach to combat multidrug resistance in Salmonella typhi and human colon cancer with Excoecaria agallocha L. extract
title_fullStr An in vitro approach to combat multidrug resistance in Salmonella typhi and human colon cancer with Excoecaria agallocha L. extract
title_full_unstemmed An in vitro approach to combat multidrug resistance in Salmonella typhi and human colon cancer with Excoecaria agallocha L. extract
title_short An in vitro approach to combat multidrug resistance in Salmonella typhi and human colon cancer with Excoecaria agallocha L. extract
title_sort in vitro approach to combat multidrug resistance in salmonella typhi and human colon cancer with excoecaria agallocha l extract
topic Antibacterial resistance
Bergenin
Caspase-3
Colon cancer
Excoecaria agallocha
Mangrove
url https://doi.org/10.1186/s42269-021-00668-x
work_keys_str_mv AT tamannasultana aninvitroapproachtocombatmultidrugresistanceinsalmonellatyphiandhumancoloncancerwithexcoecariaagallochalextract
AT arupkumarmitra aninvitroapproachtocombatmultidrugresistanceinsalmonellatyphiandhumancoloncancerwithexcoecariaagallochalextract
AT satadaldas aninvitroapproachtocombatmultidrugresistanceinsalmonellatyphiandhumancoloncancerwithexcoecariaagallochalextract
AT tamannasultana invitroapproachtocombatmultidrugresistanceinsalmonellatyphiandhumancoloncancerwithexcoecariaagallochalextract
AT arupkumarmitra invitroapproachtocombatmultidrugresistanceinsalmonellatyphiandhumancoloncancerwithexcoecariaagallochalextract
AT satadaldas invitroapproachtocombatmultidrugresistanceinsalmonellatyphiandhumancoloncancerwithexcoecariaagallochalextract